Acadia Pharmaceuticals Announces DAYBUE™ (trofinetide) is Now Available for the Treatment of Rett Syndrome — Commercial launch of DAYBUE offers Rett syndrome community the first and only approved therapy for Rett syndrome, a rare, neurodevelopmental disorder, which affects 6,000… Read More
Taysha Rett Program Update
Leave a Comment
Posted: 06/05/2023 by admin
Sabrina Millson, President of Ontario Rett Syndrome Association quoted, “This is a momentous day for the Rett syndrome community. As a mom to a daughter living with Rett syndrome and the president of the Ontario Rett Syndrome Association… Read More
DayBue Announcement
Leave a Comment
Last Updated: 04/20/2023 by admin
Acadia Pharmaceuticals Announces DAYBUE™ (trofinetide) is Now Available for the Treatment of Rett Syndrome — Commercial launch of DAYBUE offers Rett syndrome community the first and only approved therapy for Rett syndrome, a rare, neurodevelopmental disorder, which affects 6,000… Read More
Neurogene Announcement
Leave a Comment
Last Updated: 04/20/2023 by admin